Detection material resisting NMDAR autoantibodies in human body fluid, preparation method and application
A technology of autoantibodies and detection materials, applied in the field of biomedicine, can solve the problems of large demand for antibodies, long detection time, low sensitivity, etc., and achieve the effect of strong operation skills, short detection cycle and high detection cost
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Step 1, plasmid construction: Obtain the CDS sequence of NMDAR as the target gene, insert the target gene with restriction sites into the pShuttle-cmv plasmid vector to obtain the recombinant plasmid vector pAdEasy-NMDAR1α, and extract the plasmid for subsequent experiments after the sequencing is correct. The plasmid vector construction of the present embodiment specifically includes the following steps:
[0039]Step 1.1: Obtain the CDS sequence of NMDAR as the target gene by PCR method (artificial synthesis method is also optional), and add SalI / NotI restriction sites at both ends of the target gene;
[0040] Step 1.2: Insert the target gene with the restriction site into the pShuttle-cmv vector, the insertion site is SalI / NotI, to obtain the recombinant vector, which is named pShuttle-NMDAR1α;
[0041] Step 1.3: Sequence the recombinant plasmid pShuttle-NMDAR1α, expand and culture the correctly sequenced strains with the target gene and carrier strains (auxiliary vec...
Embodiment 2
[0063] The difference between this example and Example 1 is that the composite extract in step 3.1 is a mixture of digitonin, TritonX100, NP40, and CHAPS in a volume ratio of 1:1:1:1.
Embodiment 3
[0065] The difference between this example and Example 1 is that the composite extract in step 3.1 is a mixture of digitonin, TritonX100, NP40, and CHAPS in a volume ratio of 1:2:2:1.
[0066] When the anti-NMDAR autoantibody detection material prepared in the above examples is used to detect the NMDAR antibody in the sample, the present invention firstly prepares a new blocking material. Since some proteins in human serum and cerebrospinal fluid will non-specifically bind to antigens during the detection process and interfere with the detection results, the present invention uses a sealing material to seal the detection sample, and the implementation effect shows that the sample background can be significantly reduced, as follows A specific example of the preparation of the sealing material of the present invention is given.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com